GDC-0084

Overview

GDC-0084, a PI3K inhibitor, has been found to have probable antineoplastic effect and could pass blood-brain barrier with favourable penetration. It was just licensed to Novogen and start a Phase II trial for Glioma.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | mTOR

Product Information

• Catalog No.: B0084-474534
• CAS No.: 1382979-44-3
• Molecular Formula: C18H22N8O2
• Molecular Weight: 382.42
• Purity: 98%
• Storage: -20°C Freeze
• Solubility: DMSO: ≥ 6 mg/mL

Source

Original product source